Moneycontrol
HomeNewsIndiaPatna AIIMS charges Rs 1,500 for RT-PCR COVID-19 test, violates Bihar government order

Patna AIIMS charges Rs 1,500 for RT-PCR COVID-19 test, violates Bihar government order

Director Dr Prabhat Kumar Singh blames it on a 'software glitch', says he has ordered waiving off the charge with immediate effect.

March 13, 2021 / 18:00 IST
Story continues below Advertisement
Representative image

The All India Institute of Medical Sciences (AIIMS), Patna, has been charging patients Rs 1,500 for an RT-PCR COVID-19 test, violating the Bihar government’s order capping the cost at Rs 800, a media report said.

The Bihar government had on December 1, 2020 capped the cost of RT-PCR tests for private laboratories. Its order said: “Anyone charging more than Rs 800 for the said (RT-PCR) test… will be taken as a violation of the Epidemic Disease Act, 1897 (Amended)…”

Story continues below Advertisement

The Bihar government has said it would seek an explanation from the hospital on why it has been overcharging its general indoor patients, the Hindustan Times reported.

AIIMS-Patna Director Dr Prabhat Kumar Singh has said that the patients were overcharged due to a “software glitch” and ordered the test charge to be waived immediately.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show